TB guidelines

All Items

• 

  The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026–2030

  The National Tuberculosis Advisory Committee, on behalf of the Communicable Diseases Network Australia, Professor Justin T Denholm

• Australian recommendations for the management of drug-resistant tuberculosis, 2023

  Richard Stapledon, Ellen J Donnan, National Tuberculosis Advisory Committee (NTAC)

• The Use of whole genome sequencing for tuberculosis public health activities in Australia: a joint statement of the National Tuberculosis Advisory Committee and Communicable Diseases Genomics Network

  Ellen J Donnan, Ben J Marais, Chris Coulter, Justin Waring, ivan Bastian, Deborah A Williamson, Norelle L Sherry, Katherine Bond, Vitali Sintchenko, Ella M Meumann, Kristy Horan, Louise Cooley, Justin T Denholm

• Consensus statement on the use of a four-month treatment regimen for drug susceptible tuberculosis in children (< 10 years of age) with uncomplicated disease Endorsed by the Australian and New Zealand Paediatric Infectious Diseases (ANZPID) interest group of the Australasian Society of Infectious Diseases (ASID) and the National Tuberculosis Advisory Committee (NTAC) on behalf of the Communicable Diseases Network of Australia (CDNA)

  National Tuberculosis Advisory Committee

• Not everything that can be counted counts: defining and evaluating tuberculosis mortality in Australia

  Justin T Denholm, National Tuberculosis Advisory Committee

• The Strategic Plan for Control of Tuberculosis in Australia, 2021–2025

  National Tuberculosis Advisory Committee

• Revised guidelines for Australian laboratories performing mycobacteriology testing

  Ivan Bastian, Lisa Shephard, Richard Lumb, National Tuberculosis Advisory Committee

• The Strategic Plan for Control of Tuberculosis in Australia, 2016–2020: Towards Disease Elimination

  National Tuberculosis Advisory Committee

• Position statement on interferon-γ release assays for the detection of latent tuberculosis infection

  Ivan Bastian, Chris Coulter, National Tuberculosis Advisory Committee (NTAC)

  322-336

• National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia

  Justin Waring, National Tuberculosis Advisory Committee

  119-203

• National position statement for the management of latent tuberculosis infection

  David Stock, National Tuberculosis Advisory Committee (NTAC)

  204-208

• Defining a tuberculosis cluster or outbreak

  Justin Denholm, Chris Coulter, Ivan Bastian, National Tuberculosis Advisory Committee

  356-359

• Infection control guidelines for the management of patients with suspected or confirmed pulmonary tuberculosis in healthcare settings

  Chris Coulter, National Tuberculosis Advisory Committee (NTAC)

  360-366

• Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention

  Vicki Krause, National Tuberculosis Advisory Committee

  597-598

• Essential components of a tuberculosis control program within Australia

  National Tuberculosis Advisory Committee, Justin Waring

  397-400

• National Tuberculosis Advisory Committee 2012 Committee Report

  Emily Gearside, National Tuberculosis Advisory Committee

  187-188

• The BCG vaccine: information and recommendations for use in Australia: National Tuberculosis Advisory Committee update October 2012

  No authors listed

  65-72

• Position statement on interferon-γ release assays in the detection of latent tuberculosis infection

  National Tuberculosis Advisory Committee

  125-131

• The BCG vaccine: information and recommendations for use in Australia

  National Tuberculosis Advisory Committee

  109-115

• Guidelines for Australian Mycobacteriology Laboratories

  National Tuberculosis Advisory Committee

  116-128